PE20070612A1 - Nuevos inhibidores de cisteina proteasas - Google Patents

Nuevos inhibidores de cisteina proteasas

Info

Publication number
PE20070612A1
PE20070612A1 PE2006001057A PE2006001057A PE20070612A1 PE 20070612 A1 PE20070612 A1 PE 20070612A1 PE 2006001057 A PE2006001057 A PE 2006001057A PE 2006001057 A PE2006001057 A PE 2006001057A PE 20070612 A1 PE20070612 A1 PE 20070612A1
Authority
PE
Peru
Prior art keywords
saturated
benzohydrazide
alkylen
methylpropyl
pyrimidinyl
Prior art date
Application number
PE2006001057A
Other languages
English (en)
Inventor
Martin Maria Jesus Chaparro
Lopez Jose Miguel Coteron
Roman Jose Maria Fiandor
Martin Maria Marco
Velando Esther Pilar Fernandez
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20070612A1 publication Critical patent/PE20070612A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE R4 ES HALOGENO, R2 ES FENIL-(ALQUILEN-C1-C3)-X, PIRIDIL-FENIL-ALQUILEN C1-C3-X, FENIL-ALQUILEN C1-C3-X-RJ, DONDE FENILO ESTA OPCIONALMENTE SUSTITUIDO POR CF3; RJ ES Z, -ALQUILEN C1-C4-Z, -C(O)Z; X Y Z SON CADA UNO GRUPO HIDROCARBONADO MONOCICLICO SATURADO DE 4 MIEMBROS QUE CONTIENE N, GRUPO HIDROCARBONADO SATURADO MONOCICLICO, PARCIALMENTE SATURADO O AROMATICO DE 6 ATOMOS, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: N'-(5-BROMO-2-CIANO-4-PIRIMIDINIL)-N'-(2-METILPROPIL)-3-[(4-PROPIL-1-PIPERAZINIL)METIL]BENZOHIDRAZIDA; N'-(5-CLORO-2-CIANO-4-PIRIMIDINIL)-4-({4-[3-(DIETILAMINO)PROPIL]-1-PIPERAZINIL}METIL)-N'-(2-METILPROPIL)BENZOHIDRAZIDA; 4-(1-AZETIDINILMETIL)-N'-(5-BROMO-2-CIANO-PIRIMIDINIL)-N'-(2-METILPROPIL)BENZOHIDRAZIDA. REFERIDA TAMBIEN A UN PROCESO Y UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE PROTEASA CON ACTIVIDAD ANTIMALARICA
PE2006001057A 2005-09-02 2006-08-31 Nuevos inhibidores de cisteina proteasas PE20070612A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05381043 2005-09-02
EP06110666 2006-03-03

Publications (1)

Publication Number Publication Date
PE20070612A1 true PE20070612A1 (es) 2007-06-23

Family

ID=37770277

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2006001057A PE20070612A1 (es) 2005-09-02 2006-08-31 Nuevos inhibidores de cisteina proteasas
PE2006001056A PE20070332A1 (es) 2005-09-02 2006-08-31 Compuestos heteroaril-nitrilos sustituidos como inhibidores de cisteina proteasas

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2006001056A PE20070332A1 (es) 2005-09-02 2006-08-31 Compuestos heteroaril-nitrilos sustituidos como inhibidores de cisteina proteasas

Country Status (4)

Country Link
AR (2) AR055624A1 (es)
PE (2) PE20070612A1 (es)
TW (2) TW200804351A (es)
WO (3) WO2007025774A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2030621A1 (en) * 2007-08-21 2009-03-04 Glaxo Group Limited Novel substituted pyrimidines as cysteine protease inhibitors
JP2010508322A (ja) * 2006-10-30 2010-03-18 グラクソ グループ リミテッド システインプロテアーゼ阻害薬としての新規置換ピリジン誘導体
EP2168600A1 (en) 2007-06-08 2010-03-31 Nippon Chemiphar Co., Ltd. Therapeutic or prophylactic agent for cerebral aneurysm
JPWO2009054454A1 (ja) 2007-10-24 2011-03-03 国立大学法人 東京医科歯科大学 カテプシン阻害剤を有効成分として含有するＴｏｌｌ様受容体のシグナル伝達の調整剤
DE102008063561A1 (de) * 2008-12-18 2010-08-19 Bayer Cropscience Ag Hydrazide, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Insektizide
CN102267964B (zh) * 2011-06-15 2014-06-18 浙江师范大学 3-羟基-2,3-二氢苯并呋喃衍生物及其合成方法和应用
EP3778576B1 (en) * 2018-03-28 2024-04-17 Hanlim Pharmaceutical Co., Ltd. 2-cyanopyrimidin-4-yl carbamate or urea derivative or salt thereof, and pharmaceutical composition including same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR036375A1 (es) * 2001-08-30 2004-09-01 Novartis Ag Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos

Also Published As

Publication number Publication date
WO2007025774A2 (en) 2007-03-08
AR057110A1 (es) 2007-11-14
WO2007025774A3 (en) 2007-04-26
WO2007025776A3 (en) 2007-05-03
TW200804351A (en) 2008-01-16
WO2007025776A2 (en) 2007-03-08
TW200804352A (en) 2008-01-16
PE20070332A1 (es) 2007-05-11
WO2007025775A2 (en) 2007-03-08
AR055624A1 (es) 2007-08-29

Similar Documents

Publication Publication Date Title
PE20070612A1 (es) Nuevos inhibidores de cisteina proteasas
RU2436776C2 (ru) ДИАРИЛАМИН-СОДЕРЖАЩИЕ СОЕДИНЕНИЯ, КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ МОДУЛЯТОРОВ РЕЦЕПТОРОВ с-КIT
BR122012009534B8 (pt) 4-[2-(4-metil-fenil-sulfanil)-fenil]-piperidina, seu uso e composição farmacêutica compreendendo o referido composto
PE20050018A1 (es) Compuesto pentaciclico heteroaromatico como inhibidor de la proteina tirosina fosfatasa 1b (ptb1b)
PE20120119A1 (es) AGENTES INDUCTORES DE APOPTOSIS CON SELECTIVIDAD POR Bcl-2
PE20040647A1 (es) Inhibidores de cinasas de tirosina
PE20110341A1 (es) COMPUESTOS HETEROCICLICOS QUE MODULAN LA ACTIVIDAD DE LA ESTEROIL-CoA-DESATURASA
PE20121385A1 (es) DERIVADOS DE SULFONAMIDA COMO AGENTES INDUCTORES DE APOPTOSIS CON SELECTIVIDAD POR Bcl-2 PARA EL TRATAMIENTO DE CANCER Y ENFERMEDADES INMUNES
PE20060693A1 (es) Nuevos derivados de trifluorometansulfonanilida oxamida eter
PE20090641A1 (es) Amidas heterociclicas
CO5690568A2 (es) Agonismo del receptor de 5ht2a para el tratamiento de disfun cion termorreguladora
PE20080061A1 (es) Compuestos derivados de amida como inhibidores de los canales de potasio task-1 y task-3
AR051965A1 (es) Sales de la n-[2-( { (3r)-1-[trans-4-hidroxi-4-(6- metoxipiridin-3-il)-ciclohexil] pirrolidin-3- il} amino)-2- oxoetil]-3-(trifluormetil) benzamida
PE20080069A1 (es) Compuestos biciclicos como agonistas del receptor 40 acoplado a proteina g (gpr40)
PE20030968A1 (es) Derivados de 5-feniltiazol como inhibidores de cinasas
PE20141375A1 (es) Activadores de glucoquinasa
NO20062942L (no) Fremgangsmate for fremstilling av en fast, oralt anvendelig farmasoytisk sammensetning
PE20060651A1 (es) Compuestos de aminoheteroarilo sustituidos con pirazol como inhibidores de proteina quinasa
CY1114118T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν λουρασιδονη
PE20121314A1 (es) Derivados de 4-aminociclohexano sustituido
PE20061366A1 (es) Compuestos y composiciones como inhibidores de quinasa de proteina
PE20081471A1 (es) Derivados de heteroarilnitrilo como inhibidores de cisteina proteasa
NO20075087L (no) Kombinasjoner, metoder og sammensetninger for behandling av cancer
PE20061373A1 (es) Composicion farmaceutica que contiene 'n-(2-cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil]-2-metil-4-pirimidinil]amino]-5-tiazolcarboxamida
PE20061394A1 (es) Metabolitos de n-(2-cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil]-2-metil-4-pirimidinil]amino]-5-tiazolcarboxamidas

Legal Events

Date Code Title Description
FD Application declared void or lapsed